Overview

Phase II Sunitinib Prog Met AIPC

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out what effects (good and bad) Sutent has on you and your prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
US Oncology Research
Collaborator:
Pfizer
Treatments:
Sunitinib